The U.S. Food and Drug Administration (FDA) is reviewing the regulation and labeling of the abortion pill mifepristone following new evidence of safety concerns regarding its current use ...

In a court brief filed April 5, the Trump administration did not debate the legality of the pill or defend its use in almost two-thirds of pregnancy terminations in the U.S. Rather, the Justice ...